DPP4 and acute pancreatitis: In summary, based on this extensive nationwide cohort study in Taiwan with a significant number of incident cases, the use of DPP-4 inhibitors appears to be unrelated to an increased risk of recurrent acute pancreatitis, in those who have a prior history of acute pancreatitis in stable condition.